Chaperone Proteins Gain Renewed Interest As Cancer Drug Target
By Daniel Cressey of Nature magazineChaperone proteins could be the key to treating a range of diseases, including some cancers. Drugs that inhibit the function of these proteins, which help other proteins in the body to fold, are the focus of renewed research, despite the fact that for years many considered them too unorthodox a target to risk precious research dollars on.Ten years ago, Paul Workman, director of the Cancer Therapeutics Unit at the Institute of Cancer Research in Sutton, UK, was one of only a few people pushing to develop drugs that target a chaperone protein called heat shock protein 90 (Hsp90)....